LUCENTIS®


Solution for injection
scheduling status
S4
registration number
41/15.4/0860
What LUCENTIS® contains
One mL contains 10 mg ranibizumab. Each vial contains 2.3 mg of ranibizumab in 0.23 ml solution.
other ingredients
α,α-trehalose dihydrate, Histidine hydrochloride monohydrate, Histidine, Polysorbate 20, Water for injections.
Therapeutic classification
S01LA04.
© 2026 SAHPRA. ALL RIGHTS RESERVED